Pazarentzos, E http://orcid.org/0000-0002-5453-1646
Giannikopoulos, P
Hrustanovic, G
St John, J
Olivas, V R
Gubens, M A
Balassanian, R
Weissman, J
Polkinghorn, W
Bivona, T G
Article History
Received: 2 February 2015
Revised: 7 April 2015
Accepted: 12 April 2015
First Online: 18 May 2015
Competing interests
: TGB is a consultant to Driver Group, Novartis, Clovis Oncology and Cleave Biosciences, and has received a research grant from Servier; JW is a consultant to Driver Group; PG, JSJ and WP are employees of Driver Group. The remaining authors declare no conflict of interest.